Evidence map›Paper›PMID 35783852›Full record

ReviewFrontiers in cardiovascular medicine2022

Stem Cell Based Approaches to Modulate the Matrix Milieu in Vascular Disorders.

Sajeesh S, Shataakshi Dahal, Suraj Bastola, Simran Dayal, Jimmy Yau, Anand Ramamurthi

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sajeesh SDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United States.
Shataakshi DahalDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United States.
Suraj BastolaDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United States.
Simran DayalDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United States.
Jimmy YauDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United States.
Anand RamamurthiDepartment of Bioengineering, Lehigh University, Bethlehem, PA, United States.
Lehigh University · US

Funding

Matrix Regenerative Nanotherapeutics for Small Abdominal Aortic Aneurysm RepairR01HL139662 · NHLBI · LEHIGH UNIVERSITY · PI RAMAMURTHI, ANAND · 2018 to 2021
$1.6M
NHLBI NIH HHS R01 HL139662
6 · The paper itself

Abstract

The extracellular matrix (ECM) represents a complex and dynamic framework for cells, characterized by tissue-specific biophysical, mechanical, and biochemical properties. ECM components in vascular tissues provide structural support to vascular cells and modulate their function through interaction with specific cell-surface receptors. ECM-cell interactions, together with neurotransmitters, cytokines, hormones and mechanical forces imposed by blood flow, modulate the structural organization of the vascular wall. Changes in the ECM microenvironment, as in post-injury degradation or remodeling, lead to both altered tissue function and exacerbation of vascular pathologies. Regeneration and repair of the ECM are thus critical toward reinstating vascular homeostasis. The self-renewal and transdifferentiating potential of stem cells (SCs) into other cell lineages represents a potentially useful approach in regenerative medicine, and SC-based approaches hold great promise in the development of novel therapeutics toward ECM repair. Certain adult SCs, including mesenchymal stem cells (MSCs), possess a broader plasticity and differentiation potential, and thus represent a viable option for SC-based therapeutics. However, there are significant challenges to SC therapies including, but not limited to cell processing and scaleup, quality control, phenotypic integrity in a disease milieu

Indexed as

cardiovascularcollagenECMelastinexosomesregenerative repair

Identifiers

PMID35783852
PMCPMC9242410
OpenAlexW4282934756

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.